Cargando…
Analysis of Ischemia-Modified Albumin (IMA) and Coagulation Parameters in Patients with SARS-CoV-2 Pneumonia
Background: Coronavirus disease 2019 (COVID-19) is a systemic disease which causes an increased inclination to thrombosis by leading to coagulation system activation and endothelial dysfunction. Our objective in this study is to determine whether ischemia-modified albumin (IMA) can be used as a new...
Autores principales: | Saglam, Emel, Sener, Gulsen, Bayrak, Tulin, Bayrak, Ahmet, Gorgulu, Numan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342497/ https://www.ncbi.nlm.nih.gov/pubmed/37445341 http://dx.doi.org/10.3390/jcm12134304 |
Ejemplares similares
-
Value of thiol and ischemia modified albumin (IMA) in predicting mortality in serious COVID-19 pneumonia
por: Acar, Tarik, et al.
Publicado: (2022) -
Study of ischemia modified albumin (IMA) as a biomarker in hypertensive retinopathy
por: Pavlovschi, Ecaterina, et al.
Publicado: (2021) -
Ischemia-modified albumin (IMA) is not useful for detecting myocardial ischemia during symptom-limited exercise stress tests
por: Kim, June Hong, et al.
Publicado: (2008) -
A Novel Biomarker in Primary Glaucoma: Aqueous Humor and Serum Levels of Ischemia Modified Albumin (IMA)
por: Rusmayani, Emma, et al.
Publicado: (2022) -
Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study
por: Çavuşoğlu, Yüksel, et al.
Publicado: (2016)